{"count": 38, "results": [{"_id": "37031209", "pmid": 37031209, "pmcid": "PMC10082807", "title": "Impact of porous microsponges in minimizing myotoxic side effects of simvastatin", "journal": "Sci Rep", "authors": ["Ali AU", "Abd-Elkareem M", "Kamel AA", "Abou Khalil NS", "Hamad D", "Nasr NEH", "Hassan MA", "El Faham TH"], "date": "2023-04-08T00:00:00Z", "doi": "10.1038/s41598-023-32545-0", "meta_date_publication": "2023 Apr 8", "meta_volume": "13", "meta_issue": "1", "meta_pages": "5790", "score": 50307.637, "text_hl": "Impact of porous microsponges in minimizing @<m>DISEASE_Myotoxicity</m> @DISEASE_MESH:D000081030 @@@myotoxic@@@ side effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@", "citations": {"NLM": "Ali AU, Abd-Elkareem M, Kamel AA, Abou Khalil NS, Hamad D, Nasr NEH, Hassan MA, El Faham TH. Impact of porous microsponges in minimizing myotoxic side effects of simvastatin Sci Rep. 2023 Apr 8;13(1):5790. PMID: 37031209", "BibTeX": "@article{37031209, title={Impact of porous microsponges in minimizing myotoxic side effects of simvastatin}, author={Ali AU and Abd-Elkareem M and Kamel AA and Abou Khalil NS and Hamad D and Nasr NEH and Hassan MA and El Faham TH}, journal={Sci Rep}, volume={13}, number={1}, pages={5790}}"}}, {"_id": "40774408", "pmid": 40774408, "title": "Relationship between simvastatin pharmacokinetics and muscle toxicity in male mice.", "journal": "Food Chem Toxicol", "authors": ["Bouitbir J", "Sanvee GM", "Panajatovic MV", "Fehrenbach NB", "Fréchard T", "Manivannan M", "Duthaler U", "Krähenbühl S"], "date": "2025-08-05T00:00:00Z", "doi": "10.1016/j.fct.2025.115688", "meta_date_publication": "2025 Aug 5", "meta_volume": "205", "meta_issue": "", "meta_pages": "115688", "score": 50278.49, "text_hl": "At 25 mg/kg @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, @<m>DISEASE_Myotoxicity</m> @DISEASE_MESH:D000081030 @@@myotoxicity@@@ is less accentuated than at 10 mg/kg, possibly due to induction of protective mechanisms.", "citations": {"NLM": "Bouitbir J, Sanvee GM, Panajatovic MV, Fehrenbach NB, Fréchard T, Manivannan M, Duthaler U, Krähenbühl S. Relationship between simvastatin pharmacokinetics and muscle toxicity in male mice. Food Chem Toxicol. 2025 Aug 5;205():115688. PMID: 40774408", "BibTeX": "@article{40774408, title={Relationship between simvastatin pharmacokinetics and muscle toxicity in male mice.}, author={Bouitbir J and Sanvee GM and Panajatovic MV and Fehrenbach NB and Fréchard T and Manivannan M and Duthaler U and Krähenbühl S}, journal={Food Chem Toxicol}, volume={205}, pages={115688}}"}}, {"_id": "34296883", "pmid": 34296883, "title": "Modulation of Phospholipid Bilayer Properties by Simvastatin.", "journal": "J Phys Chem B", "authors": ["Teo RD", "Tieleman DP"], "date": "2021-08-05T00:00:00Z", "doi": "10.1021/acs.jpcb.1c03359", "meta_date_publication": "2021 Aug 5", "meta_volume": "125", "meta_issue": "30", "meta_pages": "8406-8418", "score": 50273.98, "text_hl": "Unfortunately, some of the side effects associated with the intake of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and other lipophilic statins at higher doses include statin-associated @DISEASE_Muscular_Diseases @DISEASE_MESH:D009135 @@@myopathy@@@ (@<m>DISEASE_Myotoxicity</m> @DISEASE_MESH:D000081030 @@@SAM@@@) and, in more severe cases, @DISEASE_Renal_Insufficiency @DISEASE_MESH:D051437 @@@kidney failure@@@. ", "citations": {"NLM": "Teo RD, Tieleman DP. Modulation of Phospholipid Bilayer Properties by Simvastatin. J Phys Chem B. 2021 Aug 5;125(30):8406-8418. PMID: 34296883", "BibTeX": "@article{34296883, title={Modulation of Phospholipid Bilayer Properties by Simvastatin.}, author={Teo RD and Tieleman DP}, journal={J Phys Chem B}, volume={125}, number={30}, pages={8406-8418}}"}}, {"_id": "35671582", "pmid": 35671582, "title": "l-Carnitine ameliorates the osteoporotic changes and protects against simvastatin induced myotoxicity and hepatotoxicity in glucocorticoid-induced osteoporosis in rats.", "journal": "Biomed Pharmacother", "authors": ["Ahmed SA", "Abd El Reheem MH", "Elbahy DA"], "date": "2022-08-01T00:00:00Z", "doi": "10.1016/j.biopha.2022.113221", "meta_date_publication": "2022 Aug", "meta_volume": "152", "meta_issue": "", "meta_pages": "113221", "score": 50269.348, "text_hl": "Moreover, @CHEMICAL_Carnitine @CHEMICAL_MESH:D002331 @@@L-Car@@@ ameliorates @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIMV@@@-induced @<m>DISEASE_Myotoxicity</m> @DISEASE_MESH:D000081030 @@@myotoxicity@@@ and hepatoxicity.", "citations": {"NLM": "Ahmed SA, Abd El Reheem MH, Elbahy DA. l-Carnitine ameliorates the osteoporotic changes and protects against simvastatin induced myotoxicity and hepatotoxicity in glucocorticoid-induced osteoporosis in rats. Biomed Pharmacother. 2022 Aug;152():113221. PMID: 35671582", "BibTeX": "@article{35671582, title={l-Carnitine ameliorates the osteoporotic changes and protects against simvastatin induced myotoxicity and hepatotoxicity in glucocorticoid-induced osteoporosis in rats.}, author={Ahmed SA and Abd El Reheem MH and Elbahy DA}, journal={Biomed Pharmacother}, volume={152}, pages={113221}}"}}, {"_id": "31605661", "pmid": 31605661, "title": "PGC-1alpha plays a pivotal role in simvastatin-induced exercise impairment in mice.", "journal": "Acta Physiol (Oxf)", "authors": ["Panajatovic MV", "Singh F", "Roos NJ", "Duthaler U", "Handschin C", "Krähenbühl S", "Bouitbir J"], "date": "2020-04-01T00:00:00Z", "doi": "10.1111/apha.13402", "meta_date_publication": "2020 Apr", "meta_volume": "228", "meta_issue": "4", "meta_pages": "e13402", "score": 50264.285, "text_hl": "CONCLUSIONS: @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ impairs skeletal muscle function, muscle oxidative metabolism and mitochondrial morphology preferentially in WT and KO @SPECIES_10090 @@@mice@@@, whereas OE @SPECIES_10090 @@@mice@@@ appear to be protected, suggesting a role of @GENE_PPARGC1A @GENE_19017 @@@PGC-1alpha@@@ in preventing @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-associated @<m>DISEASE_Myotoxicity</m> @DISEASE_MESH:D000081030 @@@myotoxicity@@@.", "citations": {"NLM": "Panajatovic MV, Singh F, Roos NJ, Duthaler U, Handschin C, Krähenbühl S, Bouitbir J. PGC-1alpha plays a pivotal role in simvastatin-induced exercise impairment in mice. Acta Physiol (Oxf). 2020 Apr;228(4):e13402. PMID: 31605661", "BibTeX": "@article{31605661, title={PGC-1alpha plays a pivotal role in simvastatin-induced exercise impairment in mice.}, author={Panajatovic MV and Singh F and Roos NJ and Duthaler U and Handschin C and Krähenbühl S and Bouitbir J}, journal={Acta Physiol (Oxf)}, volume={228}, number={4}, pages={e13402}}"}}, {"_id": "34461118", "pmid": 34461118, "title": "mTORC2 is an important target for simvastatin-associated toxicity in C2C12 cells and mouse skeletal muscle - Roles of Rap1 geranylgeranylation and mitochondrial dysfunction.", "journal": "Biochem Pharmacol", "authors": ["Sanvee GM", "Hitzfeld L", "Bouitbir J", "Krähenbühl S"], "date": "2021-10-01T00:00:00Z", "doi": "10.1016/j.bcp.2021.114750", "meta_date_publication": "2021 Oct", "meta_volume": "192", "meta_issue": "", "meta_pages": "114750", "score": 50262.887, "text_hl": "In conclusion, @GENE_CRTC2 @GENE_74343 @@@mTORC2@@@ inhibition is an important mechanism of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-induced @<m>DISEASE_Myotoxicity</m> @DISEASE_MESH:D000081030 @@@myotoxicity@@@. ", "citations": {"NLM": "Sanvee GM, Hitzfeld L, Bouitbir J, Krähenbühl S. mTORC2 is an important target for simvastatin-associated toxicity in C2C12 cells and mouse skeletal muscle - Roles of Rap1 geranylgeranylation and mitochondrial dysfunction. Biochem Pharmacol. 2021 Oct;192():114750. PMID: 34461118", "BibTeX": "@article{34461118, title={mTORC2 is an important target for simvastatin-associated toxicity in C2C12 cells and mouse skeletal muscle - Roles of Rap1 geranylgeranylation and mitochondrial dysfunction.}, author={Sanvee GM and Hitzfeld L and Bouitbir J and Krähenbühl S}, journal={Biochem Pharmacol}, volume={192}, pages={114750}}"}}, {"_id": "34114646", "pmid": 34114646, "title": "Effect of SLCO1B1 T521C on Statin-Related Myotoxicity With Use of Lovastatin and Atorvastatin.", "journal": "Clin Pharmacol Ther", "authors": ["Lu B", "Sun L", "Seraydarian M", "Hoffmann TJ", "Medina MW", "Risch N", "Iribarren C", "Krauss RM", "Oni-Orisan A"], "date": "2021-09-01T00:00:00Z", "doi": "10.1002/cpt.2337", "meta_date_publication": "2021 Sep", "meta_volume": "110", "meta_issue": "3", "meta_pages": "733-740", "score": 50262.53, "text_hl": "To validate the drug response phenotype, we replicated the previously established association between @VARIANT_c.521T>C_SLCO1B1_human @VARIANT_tmVar:rs4149056;VariantGroup:0;CorrespondingGene:10599;RS#:4149056;CorrespondingSpecies:9606 @@@rs4149056@@@ genotype and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-induced @<m>DISEASE_Myotoxicity</m> @DISEASE_MESH:D000081030 @@@myotoxicity@@@. ", "citations": {"NLM": "Lu B, Sun L, Seraydarian M, Hoffmann TJ, Medina MW, Risch N, Iribarren C, Krauss RM, Oni-Orisan A. Effect of SLCO1B1 T521C on Statin-Related Myotoxicity With Use of Lovastatin and Atorvastatin. Clin Pharmacol Ther. 2021 Sep;110(3):733-740. PMID: 34114646", "BibTeX": "@article{34114646, title={Effect of SLCO1B1 T521C on Statin-Related Myotoxicity With Use of Lovastatin and Atorvastatin.}, author={Lu B and Sun L and Seraydarian M and Hoffmann TJ and Medina MW and Risch N and Iribarren C and Krauss RM and Oni-Orisan A}, journal={Clin Pharmacol Ther}, volume={110}, number={3}, pages={733-740}}"}}, {"_id": "33705623", "pmid": 33705623, "pmcid": "PMC8524017", "title": "Combination of Simvastatin and FAC Improves Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer", "journal": "Cancer Res Treat", "authors": ["Yulian ED", "Siregar NC", "Bajuadji"], "date": "2021-10-01T00:00:00Z", "doi": "10.4143/crt.2020.1024", "meta_date_publication": "2021 Oct", "meta_volume": "53", "meta_issue": "4", "meta_pages": "1072-1083", "score": 50258.434, "text_hl": "The pathological CR rate was 6.25% (2 in @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ group and 1 in placebo group). ", "citations": {"NLM": "Yulian ED, Siregar NC, Bajuadji. Combination of Simvastatin and FAC Improves Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Cancer Res Treat. 2021 Oct;53(4):1072-1083. PMID: 33705623", "BibTeX": "@article{33705623, title={Combination of Simvastatin and FAC Improves Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer}, author={Yulian ED and Siregar NC and Bajuadji}, journal={Cancer Res Treat}, volume={53}, number={4}, pages={1072-1083}}"}}, {"_id": "33150478", "pmid": 33150478, "title": "Correlation between single-nucleotide polymorphisms and statin-induced myopathy: a mixed-effects model meta-analysis.", "journal": "Eur J Clin Pharmacol", "authors": ["Xiang Q", "Zhang XD", "Mu GY", "Wang Z", "Liu ZY", "Xie QF", "Hu K", "Zhang Z", "Ma LY", "Jiang J", "Cui YM"], "date": "2021-04-01T00:00:00Z", "doi": "10.1007/s00228-020-03029-1", "meta_date_publication": "2021 Apr", "meta_volume": "77", "meta_issue": "4", "meta_pages": "569-581", "score": 50256.98, "text_hl": "Moreover, an increased risk of @<m>DISEASE_Myotoxicity</m> @DISEASE_MESH:D000081030 @@@SIM@@@ was predicted for carriers of the @VARIANT_c.521T>C_SLCO1B1_human @VARIANT_tmVar:rs4149056;VariantGroup:1;CorrespondingGene:10599;RS#:4149056;CorrespondingSpecies:9606 @@@rs4149056@@@ C allele among @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-treated @SPECIES_9606 @@@patients@@@, whereas carriers of the @GENE_GATM @GENE_2628 @@@GATM@@@ @VARIANT_rs9806699 @VARIANT_tmVar:rs9806699;VariantGroup:0;RS#:9806699 @@@rs9806699@@@ A allele among @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@-treated @SPECIES_9606 @@@patients@@@ had a lower risk of @<m>DISEASE_Myotoxicity</m> @DISEASE_MESH:D000081030 @@@SIM@@@. ", "citations": {"NLM": "Xiang Q, Zhang XD, Mu GY, Wang Z, Liu ZY, Xie QF, Hu K, Zhang Z, Ma LY, Jiang J, Cui YM. Correlation between single-nucleotide polymorphisms and statin-induced myopathy: a mixed-effects model meta-analysis. Eur J Clin Pharmacol. 2021 Apr;77(4):569-581. PMID: 33150478", "BibTeX": "@article{33150478, title={Correlation between single-nucleotide polymorphisms and statin-induced myopathy: a mixed-effects model meta-analysis.}, author={Xiang Q and Zhang XD and Mu GY and Wang Z and Liu ZY and Xie QF and Hu K and Zhang Z and Ma LY and Jiang J and Cui YM}, journal={Eur J Clin Pharmacol}, volume={77}, number={4}, pages={569-581}}"}}, {"_id": "32230890", "pmid": 32230890, "pmcid": "PMC7180799", "title": "Lysophosphatidic Acid Inhibits Simvastatin-Induced Myocytoxicity by Activating LPA Receptor/PKC Pathway", "journal": "Molecules", "authors": ["Won KJ", "Goh YJ", "Hwang SH"], "date": "2020-03-27T00:00:00Z", "doi": "10.3390/molecules25071529", "meta_date_publication": "2020 Mar 27", "meta_volume": "25", "meta_issue": "7", "meta_pages": "", "score": 50255.65, "text_hl": "Therefore, @CHEMICAL_lysophosphatidic_acid @CHEMICAL_MESH:C032881 @@@LPA@@@ might have potential as a bioactive molecule to protect muscles against @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-induced @<m>DISEASE_Myotoxicity</m> @DISEASE_MESH:D000081030 @@@myotoxicity@@@.", "citations": {"NLM": "Won KJ, Goh YJ, Hwang SH. Lysophosphatidic Acid Inhibits Simvastatin-Induced Myocytoxicity by Activating LPA Receptor/PKC Pathway Molecules. 2020 Mar 27;25(7):. PMID: 32230890", "BibTeX": "@article{32230890, title={Lysophosphatidic Acid Inhibits Simvastatin-Induced Myocytoxicity by Activating LPA Receptor/PKC Pathway}, author={Won KJ and Goh YJ and Hwang SH}, journal={Molecules}, volume={25}, number={7}}"}}]}